Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera vs Subcutaneous Insulin in Adult T1DM
NCT00137046Phase 3Terminated
- Sponsor
- Pfizer
- Start
- May 2002
- Primary completion
- Dec 2008
- Modality
- Biologic
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of insulin human in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Pfizer. Primary endpoints: Change From Baseline in Forced Expiratory Volume in One Second (FEV1), Summary of ≥ 15% Decliners in Forced Expiratory Volume in One Second (FEV1) and 2 more. Started May 2002; status: terminated.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00137046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137046.